BioPharma APAC - Leading Source of Biopharmaceutical Intelligence in Asia Pacific

When America Builds a Wall: Who Inherits China’s Displaced Biotech Work?

When President Trump signed the FY2026 National Defense Authorization Act on December 18, 2025, the biopharmaceutical industry finally got the law it had s...

June 02, 2026 | Analysis | By arcilla.fran@biopharmaapac.com

Kazia Therapeutics Expands Paxalisib TNBC Trial Following Encouraging Early Safety Data

Planned Enrollment to Increase from 12 to 36 Patients Following Continued Encouraging Safety and Tolerability Data Kazia Therapeutics Limited (NASDAQ...

May 28, 2026 | News

Leads Biolabs Secures China Phase III Approval For Opamtistomig In First Line EP NEC Treatment

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that its proprietary PD-L1/4-1BB bispecific antibod...

May 20, 2026 | News

Ferring Pharmaceuticals Reports Real World Evidence Supporting ADSTILADRIN Re Induction In BCG Unresponsive Bladder Cancer

Re-induction with ADSTILADRIN resulted in complete responses in 31% of initial non-responders with Bacillus Calmette-Guérin (BCG)-unresponsive n...

May 19, 2026 | News

AstraZeneca And Daiichi Sankyo Expand ENHERTU Into Early HER2 Positive Breast Cancer Treatment In The US

Approved for use before surgery based on DESTINY-Breast11 Phase III trial Approved for use following surgery based on DESTINY-Breast05 Phase III trial ...

May 19, 2026 | News

Akeso, Inc. Highlights Promising Phase II AML Data For Ligufalimab Combination At EHA 2026

Akeso, Inc. announced that compelling results from its randomized, double-blind, placebo-controlled Phase II trial (AK117-206) of ligufalimab (AK117) will ...

May 18, 2026 | News

Sino Biological Europe GmbH Launches EliteScience VIP Partnership Program For European Researchers

Sino Biological Europe GmbH, the regional subsidiary of global life science reagent and service provider Sino Biological, has recently launched its El...

May 13, 2026 | News

Quantum Breakthrough Enables Largest Ever Protein Simulations Advancing Drug Discovery Potential

Scientists at Cleveland Clinic, RIKEN, and IBM (NYSE: IBM) have used IBM quantum computers and two of the world's most powerful supercomputers to simu...

May 06, 2026 | News

Australia Approves First RNAi Therapy For Familial Chylomicronemia Syndrome

– REDEMPLO is the first and only medicine approved for use in the treatment of FCS in Australia, and is authorized for both genetically confirmed a...

May 05, 2026 | Report

WuXi Biologics Advances Global Sustainability Strategy With 2025 ESG Report

Contributing to the United Nations Sustainable Development Goals, driving equitable access to healthcare through technology and innovation Enhancing gov...

May 01, 2026 | News

Haier Biomedical Reports Strong Global Growth As AI Driven Strategy Advances Premium Brand Leadership

AI-powered growth surges as Haier Biomedical scales from product coverage to premium brand leadership, building a global life science tools and intelligent...

May 01, 2026 | News

Berlin Heals Reports Positive First In Human Results For Less Invasive CMIC Therapy In Heart Failure

High Impact Session presented at Heart Rhythm Society's Congress in Chicago First time showing results of new Less Invasive approach Improvement in Lef...

April 27, 2026 | News

Engineering Precision In Chromatography From Development To Commercial Scale

Chromatography in Bioprocessing For pilot and commercial purification of monoclonal antibodies and recombinant proteins, chromatography remains the centra...

April 24, 2026 | Analysis

Everest Medicines Reports Promising First In Human Data For Personalised mRNA Cancer Vaccine EVM16

Everest Medicines announced that the first-in-human (FIH) clinical trial data of EVM16, a proprietary personalized mRNA cancer vaccine, were presen...

April 24, 2026 | News

Stay Connected